| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.28▲ | 2.26▲ | 2.25▲ | 2.30▲ | 2.19▲ |
| MA10 | 2.26▲ | 2.26▲ | 2.27▲ | 2.28▲ | 2.87▼ |
| MA20 | 2.27▲ | 2.26▲ | 2.28▲ | 2.17▲ | 3.29▼ |
| MA50 | 2.28▲ | 2.32▼ | 2.27▲ | 3.05▼ | 1.68▲ |
| MA100 | 2.31▼ | 2.21▲ | 2.16▲ | 3.24▼ | 2.09▲ |
| MA200 | 2.20▲ | 2.16▲ | 2.41▼ | 1.88▲ | 7.62▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | 0.005▲ | -0.002▼ | 0.080▲ | -0.273▼ |
| RSI | 58.604▲ | 54.396▲ | 52.299▲ | 45.524▼ | 48.112▼ |
| STOCH | 71.875 | 42.708 | 52.083 | 62.509 | 8.991▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -36.364 | -84.900▼ |
| CCI | 81.857 | 108.436▲ | 118.519▲ | 33.419 | -72.335 |
|
Monday, March 23, 2026 06:11 AM
Potentially the Most Important Data Moment in Company HistoryEarly Blinded Results Show 40% Remission Rate Across Difficult-to-Treat Patient PopulationEnrollment Accelerating Toward 90 Subject ...
|
|
Friday, March 20, 2026 01:38 AM
Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, March 17, 2026 06:19 AM
Management to participate in fireside chat presentation with Jonathan Aschoff, Senior Research Analyst at ROTH Capital PartnersHOUSTON, March ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/04/26 | 2.18 | 2.33 | 2.18 | 2.32 | 59,669 |
| 01/04/26 | 2.26 | 2.30 | 2.20 | 2.23 | 59,400 |
| 31/03/26 | 2.27 | 2.32 | 2.20 | 2.29 | 77,399 |
| 30/03/26 | 2.38 | 2.3971 | 2.21 | 2.24 | 115,206 |
| 27/03/26 | 2.44 | 2.44 | 2.34 | 2.44 | 83,884 |
| 26/03/26 | 2.47 | 2.52 | 2.40 | 2.43 | 110,001 |
| 25/03/26 | 2.30 | 2.50 | 2.27 | 2.49 | 199,772 |
| 24/03/26 | 2.15 | 2.30 | 2.08 | 2.25 | 158,253 |
| 23/03/26 | 2.12 | 2.15 | 2.07 | 2.10 | 70,865 |
| 20/03/26 | 2.06 | 2.13 | 2.01 | 2.06 | 79,682 |
|
|
||||
|
|
||||
|
|